The past year has seen a number of changes in the pharmaceutical landscape, including the introduction of a new class of cholesterol-lowering agents and changes in the prescribing information for several commonly used agents, including those for diabetes and insomnia. Gerald Smetana, Professor of Medicine at Harvard Medical School, reviews some important new information regarding several agents commonly prescribed by primary care clinicians.
Dr. Wyatt will cover the most common sleep disorders seen in primary care settings. This includes obstructive sleep apnea, insomnia, restless legs syndrome, insufficient sleep syndrome, and shift work sleep disorder. For each, pathophysiology, diagnostic criteria and workup, treatment options, and long-term care will be discussed. He will also discuss the importance of collaborative treatment, where appropriate, with sleep disorders specialists to enhance patient care and outcomes.